Home Newsfeeds Fortress Biotech Q2 EPS $(0.10) Up From $(0.17) YoY

Fortress Biotech Q2 EPS $(0.10) Up From $(0.17) YoY

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year.

byBill Haddad

August 11, 2022

1 minute read

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year.

Applied UV Announces 1-For-5 Reverse Stock Split

By Happy Mohamed

May 30, 9:15 AM

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection

AUVI

ASP Isotopes Inc. Enters Into Memorandum Of Understanding With Second US-Based Small Modular Reactor Company To Supply High Assay Low Enriched Uranium

By Benzinga Newsdesk

November 27, 9:17 AM

-The MOU outlines terms for a proposed collaboration on the development of a facility for producing HALEU, a vital nuclear fuel of the future. This collaboration includes a plan for the SMR company to consider providing

ASPI